Neuland Laboratories (NEULANDLAB) Share Price Falls 2.03% Today

Published:   24 September 2026 at 11:49:19 AM IST

Neuland Laboratories fell 2.03% to Rs 22,037.60. The company’s market capitalisation stands at Rs 28,905.16 crore, and today’s move keeps Neuland Laboratories Share Price in focus.

Neuland Laboratories Share Price declined today as the stock closed at Rs 22,037.60, down Rs 455.70 from the previous close of Rs 22,493.30. The fall of 2.03% came after the session opened at Rs 22,498.35 and moved between Rs 22,585.00 and Rs 21,984.05. With a market capitalisation of Rs 28,905.16 crore, Neuland Laboratories is a large cap company and the day’s move is relevant for readers tracking Neuland Laboratories Share Price Today, Neuland Laboratories Stock News and Neuland Laboratories Share Price Fall. The supplied data confirms the price event, but it does not establish a company-specific catalyst. What can be verified is the exact move, the day’s price range, the turnover of Rs 2.12 crore and the company’s valuation and sector context, which together frame today’s Neuland Laboratories Share Price Update.

Neuland Laboratories (NEULANDLAB) Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 22,037.6
Previous Close	Rs 22,493.3
Today's Move	-Rs 455.70 (-2.03%)
Open	Rs 22,498.35
High	Rs 22,585
Low	Rs 21,984.05
Turnover	Rs 2.12 crore
Market Capitalisation	Rs 28,905.16 crore
Market Cap Category	Large Cap

Neuland Laboratories Share Price Today opened slightly below the prior close at Rs 22,498.35 and then traded through an intraday range of Rs 22,585.00 to Rs 21,984.05 before ending at Rs 22,037.60. That left the stock Rs 455.70 lower than the previous close of Rs 22,493.30, a decline of 2.03% for the session. The turnover was Rs 2.12 crore. On a price basis, the stock finished below the opening level and also near the lower end of the day’s range, which makes the fall visible in the session structure itself. The market-cap category supplied for Neuland Laboratories is Large Cap, and the market capitalisation of Rs 28,905.16 crore places the company well above the median in the peer set used later in this article. For readers tracking Neuland Laboratories Stock News, the key factual point is that today’s decline happened without any verified company-specific explanation in the supplied data. That sets up the need to examine valuation and fundamentals alongside the share price movement.

Neuland Laboratories Share Price is therefore best read as a same-day price fall with a clearly defined open, high, low and close rather than as a broader event story. The next step is to assess whether the company’s valuation and financial ratios provide enough context to explain why the stock remains in focus in Neuland Laboratories News Today and broader healthcare stock updates.

Neuland Laboratories (NEULANDLAB) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 28,905.16 crore
P/E Ratio	57.98x
P/B Ratio	14.28x
ROE	21.43%
ROCE	27.5%
EPS	Rs 387.98
Book Value Per Share	Rs 1,575.41
Dividend Yield	0.15%

Profitability metrics are also strong in the supplied snapshot: ROE is 21.43% and ROCE is 27.5%. Those figures show the returns generated on shareholder equity and capital employed, respectively, and they help explain why Neuland Laboratories Stock Analysis often attracts attention beyond a single day’s move. From a fundamentals perspective, the stock is not only a price story; it is also a valuation story. The mix of high P/E, high P/B, healthy EPS, strong ROE and strong ROCE makes Neuland Laboratories Share Price a stock that investors tend to evaluate through both earnings quality and multiple-based comparison. Neuland Laboratories Financial Results are not part of the supplied event catalyst, but the existing financial ratios are sufficient to provide context for the current Neuland Laboratories Share Price Today move. The next lens is ownership context, although the supplied ownership snapshot does not add percentages here, so the focus shifts naturally to sector and peer benchmarks.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Industry	Pharmaceuticals & Drugs
Benchmark Scope	same industry
Company P/E Ratio	57.98x
Benchmark Median P/E	31.9x
Benchmark Average P/E	50.01x
Benchmark P/E Range	3.48x to 762.66x
Company P/B Ratio	14.28x
Benchmark Median P/B	3x
Benchmark Average P/B	4.38x
Company ROE	21.43%
Benchmark Median ROE	11.7%
Benchmark Average ROE	10.65%
Company ROCE	27.5%
Benchmark Median ROCE	13.46%
Benchmark Average ROCE	13.26%
Company Market Capitalisation	Rs 28,905.16 crore
Benchmark Median Market Cap	Rs 761.61 crore
Benchmark Average Market Cap	Rs 14,299.75 crore

Neuland Laboratories operates in Healthcare within the Pharmaceuticals & Drugs industry, and the supplied benchmark universe covers the same industry with 200 companies. In that benchmark set, the company’s P/E of 57.98 is above the median of 31.9 and above the average of 50.01, while remaining far below the maximum of 762.66. Its P/B of 14.28 is well above the median of 3 and also above the average of 4.38. ROE at 21.43% is above the benchmark median of 11.7% and average of 10.65%, and ROCE at 27.5% is above the benchmark median of 13.46% and average of 13.26%.

The sector benchmark also shows market capitalisation context: the median market cap in the same industry is Rs 761.61 crore, the average is Rs 14,299.75 crore, and the company’s market cap of Rs 28,905.16 crore is above both. That makes Neuland Laboratories Share Price a large-company valuation story within the pharmaceuticals space rather than a smaller company comparison. Sector analysis therefore points to a stock that is priced materially above the industry median on valuation multiples while also showing stronger-than-benchmark profitability ratios. Neuland Laboratories Share Price News today should be read against that backdrop, because the day’s decline sits inside a broader valuation conversation rather than an isolated operating metric. For readers asking why Neuland Laboratories is trending, the verified answer is that the stock combines a same-day fall with higher-than-benchmark profitability and premium valuation ratios in a large-cap healthcare setting.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Sun Pharmaceutical Industries	SUNPHARMA	4,42,437.37	37	5.17	14.85	19.11
Divi's Laboratories	DIVISLAB	2,48,053.84	87.1	14.42	16.19	21.51
Torrent Pharmaceuticals	TORNTPHARM	1,89,841.6	86.85	21.1	26.76	19.27
Zydus Lifesciences	ZYDUSLIFE	1,15,810.19	25.85	4.33	19.69	21.39
Cipla	CIPLA	1,11,565.25	33.08	3.17	11.83	16

Among the supplied peers, Neuland Laboratories Share Price sits above most of the listed market capitalisations in this group. Its Rs 28,905.16 crore market cap is below Sun Pharmaceutical Industries at Rs 4,42,437.37 crore and Divi’s Laboratories at Rs 2,48,053.84 crore, but above Torrent Pharmaceuticals at Rs 1,89,841.60 crore, Zydus Lifesciences at Rs 1,15,810.19 crore and Cipla at Rs 1,11,565.25 crore. On valuation, Neuland’s P/E of 57.98 is higher than Sun Pharma’s 37 and Cipla’s 33.08, but lower than Divi’s 87.1 and Torrent’s 86.85. Its P/B of 14.28 is well above Sun Pharma, Zydus Lifesciences and Cipla, though still below Torrent’s 21.1 and slightly below Divi’s 14.42.

On profitability, Neuland’s ROE of 21.43% is above Sun Pharma, Divi’s and Cipla, but below Torrent and Lupin among the broader peer set used in the dataset. Its ROCE of 27.5% is also strong relative to most peers, exceeded only by Lupin’s 28.86% in the broader comparison and close to Torrent’s 19.27% and Divi’s 21.51% on the supplied list. For Neuland Laboratories Share Price Today, the peer set suggests a company with a premium valuation and strong return ratios rather than a low-multiple stock. That is important for Neuland Laboratories Stock News because it frames today’s fall against a backdrop of valuation depth and industry comparison rather than a simple standalone decline.

Why Investors Are Watching Neuland Laboratories

• Neuland Laboratories Share Price fell 2.03% today to Rs 22,037.60 after closing at Rs 22,493.30 previously.
• The day’s price range was Rs 21,984.05 to Rs 22,585.00, with turnover of Rs 2.12 crore.
• The company’s market capitalisation stands at Rs 28,905.16 crore, and the market-cap category supplied is Large Cap.
• Neuland Laboratories has a P/E of 57.98, a P/B of 14.28, ROE of 21.43% and ROCE of 27.5%.
• In the same industry benchmark, the company’s P/E, P/B, ROE and ROCE are above the median values.

About Neuland Laboratories

Neuland Laboratories belongs to the Healthcare sector and the Pharmaceuticals & Drugs industry. The supplied dataset identifies the company through these classifications and supports a market-cap view of Rs 28,905.16 crore. For Neuland Laboratories Share Price readers, that classification matters because the stock is being compared with other listed pharmaceutical companies in the same industry benchmark and peer set. Neuland Laboratories Company News often appears in the context of market performance, valuation and sector comparison, and today’s event fits that pattern. The verified data in this article does not include a product mix or detailed business description, so the available company view remains focused on sector identity, industry bucket and financial metrics. That is still enough to place today’s Neuland Laboratories Share Price fall into a useful research frame for Neuland Laboratories Latest News and Neuland Laboratories Stock Performance tracking.

Track Neuland Laboratories Share Price on Univest

Use Neuland Laboratories (NEULANDLAB) live share-price page,Univest top decliners screener,Univest market blogs to review live stock data, top decliners and related market analysis.

Readers can follow Neuland Laboratories Share Price on Univest for live price updates, financial ratios, shareholding pattern, 52-week levels and market insights. Univest also brings together Neuland Laboratories Share Price Today, Neuland Laboratories Stock News and comparison data in one place so users can review the company alongside its sector and peers.

Frequently Asked Questions

Why did Neuland Laboratories Share Price fall today?

Ans.  The supplied data confirms that Neuland Laboratories Share Price fell 2.03% today, but it does not establish a company-specific catalyst. The verified facts are the close of Rs 22,037.60, the prior close of Rs 22,493.30 and the day’s price range.

What is Neuland Laboratories Share Price today?

Ans.  Neuland Laboratories Share Price today is Rs 22,037.60. It is down Rs 455.70 from the previous close of Rs 22,493.30, and the session’s high and low were Rs 22,585.00 and Rs 21,984.05 respectively.

What is the market capitalisation of Neuland Laboratories?

Ans.  Neuland Laboratories has a market capitalisation of Rs 28,905.16 crore. The supplied market-cap category is Large Cap, and that size context is useful when comparing the stock with other pharmaceuticals companies in the same industry.

How does Neuland Laboratories compare with healthcare peers?

Ans.  Neuland Laboratories trades at a higher P/E than several peers such as Sun Pharma and Cipla, while its ROE and ROCE are also above the industry benchmark median. That places its valuation and profitability in a premium bracket.

What do Neuland Laboratories fundamental ratios show?

Ans.  Neuland Laboratories has a P/E of 57.98, a P/B of 14.28, EPS of Rs 387.98, book value of Rs 1,575.41 and dividend yield of 0.15%. ROE is 21.43% and ROCE is 27.5%.

How is Neuland Laboratories positioned in the pharmaceuticals industry?

Ans.  In the same industry benchmark of 200 companies, Neuland Laboratories is above the median on P/E, P/B, ROE and ROCE. That makes the stock notable in Pharmaceuticals & Drugs within the Healthcare sector.